相关实验视频

Updated: Aug 7, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.2K

特拉斯图祖马布德鲁克斯泰干 (DS8201) 治疗晚期非小细胞肺癌,HER2外20插入突变:一个病例报告

Xincheng He1, Lei Hou1, Jun Bai1

  • 1Department of Clinical Oncology, Shaanxi Provincial People's Hospital, Xi'an.

Anti-cancer drugs
|August 24, 2023
PubMed
概括

特拉斯图祖马布德鲁克斯泰坎 (T-DXd) 有效治疗了一名患有 HER2 异构体 20 突变的晚期非小细胞肺癌 (NSCLC) 的患者. 这种新型抗体-药物联合体 (ADC) 导致显著的瘤回归和改善骨转移,为这种耐药癌症提供了新的选择.

更多相关视频

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

2.0K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...